Suchergebnisse
Katalog
Mehr
Suchmaske
Suchergebnisse einschränken oder erweitern
Aktive Suchfilter
Weniger Treffer
Art der Quelle
Thema
- united states. securities & exchange commission 936 Treffer
- biotechnology industries 650 Treffer
- health and medicine 457 Treffer
- industry classification 417 Treffer
- pharmaceutical biotechnology industry 368 Treffer
-
45 weitere Werte:
- drugs 319 Treffer
- drugs and therapies 302 Treffer
- pharmaceutical companies 249 Treffer
- securities 249 Treffer
- quarterly reports 200 Treffer
- unaudited financial statements 196 Treffer
- corporation reports 190 Treffer
- investment and finance 183 Treffer
- security holders 145 Treffer
- biological products 144 Treffer
- public companies 122 Treffer
- soleno therapeutics inc 111 Treffer
- financial statements 102 Treffer
- mimedx group inc. 81 Treffer
- surgical instruments 78 Treffer
- medical equipment 77 Treffer
- immunization 73 Treffer
- vaccines 73 Treffer
- vbi vaccines inc 73 Treffer
- biotechnology 71 Treffer
- corporate finance 67 Treffer
- biopharmaceuticals 65 Treffer
- centogene n.v. 55 Treffer
- biotechnology companies 48 Treffer
- polypid ltd. 30 Treffer
- investors 25 Treffer
- therapeutics 25 Treffer
- biopharmaceutics 21 Treffer
- drug therapy 21 Treffer
- life sciences 21 Treffer
- business enterprises 19 Treffer
- proxy statements 18 Treffer
- filing systems (documents) 17 Treffer
- bioscience 16 Treffer
- chemicals 16 Treffer
- equity securities 16 Treffer
- recursion pharmaceuticals inc. 15 Treffer
- chief compliance officers 14 Treffer
- apellis pharmaceuticals inc. 13 Treffer
- moleculin biotech inc. 13 Treffer
- vertex pharmaceuticals inc. 12 Treffer
- ani pharmaceuticals inc. 11 Treffer
- cymabay therapeutics inc. 11 Treffer
- employee benefits 11 Treffer
- recording & registration 11 Treffer
Publikation
Sprache
Geographischer Bezug
Inhaltsanbieter
1.174 Treffer
-
In: Medical Devices & Surgical Technology Week, 2024-05-30, S. 2687-2687serialPeriodicalZugriff:
-
In: Vaccine Weekly, 2024-05-03, S. 1778-1778serialPeriodicalZugriff:
-
In: Health & Medicine Week, 2024-02-02, S. 9877-9877serialPeriodicalZugriff:
-
In: Pharma Business Week, 2024-06-03, S. 1556-1556serialPeriodicalZugriff:
-
In: Pharma Business Week, 2024-06-03, S. 4375-4375serialPeriodicalZugriff:
-
In: Pharma Business Week, 2024-06-03, S. 4405-4405serialPeriodicalZugriff:
-
Stoke Therapeutics, Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Apr. 17, 2024).In: Pharma Business Week, 2024-04-30, S. 4223-4223serialPeriodicalZugriff:
-
In: Pharma Business Week, 2024-04-30, S. 2660-2660serialPeriodicalZugriff:
-
In: Pharma Business Week, 2024-04-30, S. 1570-1570serialPeriodicalZugriff:
-
In: Pharma Business Week, 2024-02-02, S. 1501-1501serialPeriodicalZugriff:
-
In: Pharma Business Week, 2024-02-02, S. 1641-1641serialPeriodicalZugriff:
-
In: Medical Devices & Surgical Technology Week, 2023-06-04, S. 2221-2221serialPeriodicalZugriff:
-
In: Health & Medicine Week, 2023-06-02, S. 9677-9677serialPeriodicalZugriff:
-
In: Pharma Business Week, 2023-12-05, S. 4440-4440serialPeriodicalZugriff:
-
In: Pharma Business Week, 2023-10-30, S. 1751-1751serialPeriodicalZugriff:
-
In: Pharma Business Week, 2023-10-30, S. 1795-1795serialPeriodicalZugriff:
-
In: Pharma Business Week, 2023-07-31, S. 1320-1320serialPeriodicalZugriff:
-
In: Pharma Business Week, 2023-07-31, S. 1335-1335serialPeriodicalZugriff:
-
In: Pharma Business Week, 2023-05-01, S. 3423-3423serialPeriodicalZugriff:
-
In: Pharma Business Week, 2023-05-01, S. 1668-1668serialPeriodicalZugriff: